• Source: Cagrilintide

Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide.




References

Kata Kunci Pencarian:

• Cagrilintide
• Cagrilintide/semaglutide
• Dual amylin and calcitonin receptor agonists
• Anti-obesity medication
• Glucagon-like peptide-1
• Retatrutide
• Dipeptidyl peptidase-4 inhibitor
• Semaglutide
• GLP-1 receptor agonist
• Tirzepatide